Reduced Mismatch Negativity is Associated with Increased Plasma Level of Glutamate in First-episode Psychosis

Reduced amplitude of mismatch negativity (MMN) is one of the more promising biological markers of schizophrenia. This finding holds true in both early and chronic phases of the disorder, and is compatible with the glutamatergic dysfunction hypothesis. To further establish MMN as a biomarker of aberr...

Descripción completa

Detalles Bibliográficos
Autores principales: Nagai, Tatsuya, Kirihara, Kenji, Tada, Mariko, Koshiyama, Daisuke, Koike, Shinsuke, Suga, Motomu, Araki, Tsuyoshi, Hashimoto, Kenji, Kasai, Kiyoto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2017
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5442101/
https://www.ncbi.nlm.nih.gov/pubmed/28536477
http://dx.doi.org/10.1038/s41598-017-02267-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5442101/
https://www.ncbi.nlm.nih.gov/pubmed/28536477
http://dx.doi.org/10.1038/s41598-017-02267-1

Ejemplares similares